Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sonoma Pharmaceuticals Inc (SNOA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11398
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, among others. It offers women’s healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare, among others. Sonoma develops its products based on shelf-stable microcyn technology platform. The company sells its products through OTC stores. The company operates in the Netherlands and the US. Sonoma is headquartered in Petaluma, California, the US.

Sonoma Pharmaceuticals Inc (SNOA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sonoma Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
Oculus Innovative Sciences Enters into Agreement with Lipogrid 10
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11
Equity Offering 12
Sonoma Pharma Prices Public Offering of Units 12
Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million 15
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million 16
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million 17
Sonoma Pharmaceuticals Inc – Key Competitors 18
Sonoma Pharmaceuticals Inc – Key Employees 19
Sonoma Pharmaceuticals Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Business Unit 20
Recent Developments 22
Financial Announcements 22
Nov 08, 2018: Sonoma Pharmaceuticals reports record revenue in second quarter FY 2019 22
Aug 08, 2018: Sonoma Pharmaceuticals reports first quarter fy 2019 financial results 24
Jun 13, 2018: Sonoma Pharmaceuticals Announces Fiscal Year And Fourth Quarter 2018 Financial Results 25
Feb 07, 2018: Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% 27
Nov 09, 2017: Sonoma Pharmaceuticals Reports Robust Top Line Growth for Second Quarter FY 2018 with 61% Product Revenue Growth and Total Revenue of $4.3 Million 29
Aug 08, 2017: Sonoma Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 31
Jun 05, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017 32
Feb 09, 2017: Sonoma Pharmaceuticals Reports Financial Results for Fiscal Third Quarter 2017 34
Corporate Communications 36
Sep 19, 2018: Sonoma Pharmaceuticals names Phillipe Weigerstorfer as Board Director 36
May 08, 2018: Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating Officer 37
Jan 31, 2017: Sonoma Pharmaceuticals Appoints Marc Umscheid As Chief Strategy And Marketing Officer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Sonoma Pharmaceuticals Inc, Medical Equipment, Key Facts, 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Oculus Innovative Sciences Enters into Agreement with Lipogrid 10
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma 11
Sonoma Pharma Prices Public Offering of Units 12
Sonoma Pharma Raises USD5 Million in Public Offering of Shares 13
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million 15
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million 16
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million 17
Sonoma Pharmaceuticals Inc, Key Competitors 18
Sonoma Pharmaceuticals Inc, Key Employees 19
Sonoma Pharmaceuticals Inc, Other Locations 20
Sonoma Pharmaceuticals Inc, Subsidiaries 20
Sonoma Pharmaceuticals Inc, Business Unit 20

List of Figures
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sonoma Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sonoma Pharmaceuticals Inc (SNOA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Crowley Maritime Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Crowley Maritime Corp (Crowley Maritime) is a transportation and logistics company that offers marine solutions and services. Its service portfolio includes shipping and logistics, Alaska fuel sales and distribution, petroleum and chemical transportation, harbor ship assist and tanker escort …
  • Herantis Pharma Plc (HRTIS):企業の財務・戦略的SWOT分析
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Partners Group Holding AG (PGHN):企業の財務・戦略的SWOT分析
    Summary Partners Group Holding AG (Partners Group) is a private market investment manager. It offers private equity and investment services. The company manages investment programs and customized portfolios for institutional investors such as insurance companies, pension funds, and sovereign wealth …
  • Nando’s Chickenland Limited:企業の戦略的SWOT分析
    Nando's Chickenland Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Shield Therapeutics Plc (STX):製薬・医療:M&Aディール及び事業提携情報
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Yangarra Resources Ltd (YGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • Enbridge Inc.:企業の戦略・SWOT・財務情報
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Peako Ltd (PKO):企業の財務・戦略的SWOT分析
    Summary Peako Ltd (Peako), formerly Peak Oil & Gas Ltd, is a mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold, silver and copper metals. Its projects include East Kimberley Region and Paterson Province. Peako’s East Kimberley Regi …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Relmada Therapeutics Inc (RLMDD):企業の財務・戦略的SWOT分析
    Summary Relmada Therapeutics Inc (Relmada Therapeutics), formerly Camp Nine Inc, is a pharmaceutical company that develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company’s product pipeline includes REL-1017 d-Methadone, an antagonist for the treat …
  • Hybio Pharmaceutical Co Ltd (300199):製薬・医療:M&Aディール及び事業提携情報
    Summary Hybio Pharmaceutical Co Ltd (Hybio) is a peptide pharmaceutical company that develops and manufactures of polypeptide drugs. The company offers peptide finished dosage products and peptide active pharmaceutical ingredients. Its finished dosage products include desmopressin for injection, ter …
  • Air Canada:戦略・SWOT・企業財務分析
    Air Canada - Strategy, SWOT and Corporate Finance Report Summary Air Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Invesco Ltd:戦略・SWOT・企業財務分析
    Invesco Ltd - Strategy, SWOT and Corporate Finance Report Summary Invesco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Murata Manufacturing Co Ltd (6981)-医療機器分野:企業M&A・提携分析
    Summary Murata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that carries out design, manufacture, and supply of advanced electronic materials, components, and multi-functional, high-density modules. Murata commercializes both finished and semi-finished goods. Its …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Royal DSM NV (DSM):医療機器:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • PanAust Ltd:企業の戦略・SWOT・財務分析
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆